The landscape of dementia prognosis has evolved considerably with the advent of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-centered tests that will detect Alzheimer's pathology several years in advance of symptoms arise. While these technological developments symbolize amazing development in being familiar with neur